Bank Of New York Mellon Corp Innoviva, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$10.73 - $13.6 $8.23 Million - $10.4 Million	766,886 New	766,886 $8.63 Billion
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $9.09 Million - $10.6 Million	770,643 New	770,643 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $166,847 - $218,726	14,371 Added 2.13%	688,969 $8 Million
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $219,239 - $304,362	-15,310 Reduced 2.22%	674,598 $9.96 Million
Q1 2022 May 11, 2022	BUY	$15.39 - $20.25 $486,585 - $640,244	31,617 Added 4.8%	689,908 $13.4 Million
Q4 2021 Feb 11, 2022	SELL	$15.91 - $18.72 $2.35 Million - $2.77 Million	-147,740 Reduced 18.33%	658,291 $11.4 Million
Q3 2021 Nov 12, 2021	SELL	$13.06 - $17.24 $436,478 - $576,178	-33,421 Reduced 3.98%	806,031 $13.5 Million
Q2 2021 Aug 11, 2021	SELL	$11.45 - $13.96 $356,621 - $434,798	-31,146 Reduced 3.58%	839,452 $11.3 Million
Q1 2021 May 13, 2021	SELL	$11.06 - $12.87 $13,150 - $15,302	-1,189 Reduced 0.14%	870,598 $10.4 Million
Q4 2020 Feb 09, 2021	BUY	$9.33 - $12.48 $549,033 - $734,398	58,846 Added 7.24%	871,787 $10.8 Million
Q3 2020 Nov 12, 2020	SELL	$10.33 - $14.49 $682,895 - $957,904	-66,108 Reduced 7.52%	812,941 $8.5 Million
Q2 2020 Aug 12, 2020	SELL	$11.49 - $15.26 $627,526 - $833,424	-54,615 Reduced 5.85%	879,049 $12.3 Million
Q1 2020 May 06, 2020	SELL	$8.11 - $15.23 $780,376 - $1.47 Million	-96,224 Reduced 9.34%	933,664 $11 Million
Q4 2019 Feb 14, 2020	BUY	$10.28 - $14.38 $517,597 - $724,033	50,350 Added 5.14%	1,029,888 $14.6 Million
Q3 2019 Nov 07, 2019	SELL	$10.05 - $14.55 $137,674 - $199,320	-13,699 Reduced 1.38%	979,538 $10.3 Million
Q2 2019 Aug 12, 2019	SELL	$13.1 - $14.95 $4.29 Million - $4.9 Million	-327,635 Reduced 24.8%	993,237 $14.5 Million
Q1 2019 May 14, 2019	BUY	$13.69 - $20.06 $4.4 Million - $6.45 Million	321,730 Added 32.2%	1,320,872 $18.5 Million
Q4 2018 Feb 11, 2019	BUY	$13.96 - $18.26 $299,120 - $391,257	21,427 Added 2.19%	999,142 $17.4 Million
Q3 2018 Nov 09, 2018	SELL	$13.63 - $15.7 $272,218 - $313,560	-19,972 Reduced 2.0%	977,715 $0
Q2 2018 Aug 06, 2018	BUY	$13.44 - $17.59 $113,877 - $149,040	8,473 Added 0.86%	997,687 $13.8 Million
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $1.25 Million - $1.54 Million	-90,461 Reduced 8.38%	989,214 $16.5 Million
Q4 2017 Feb 09, 2018	BUY	$11.73 - $14.75 $12.7 Million - $15.9 Million	1,079,675	1,079,675 $15.3 Million

Others Institutions Holding INVA

# of Institutions

228

Shares Held

79.1M

Call Options Held

37.6K

Put Options Held

300

Black Rock Inc. New York, NY

9.63M
Shares

$183 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

7.28M
Shares

$139 Million
34.93% of portfolio
Franklin Resources Inc San Mateo, CA

6.75M
Shares

$128 Million
0.04% of portfolio
Putnam Investments LLC Boston, MA

6.27M
Shares

$119 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

6.23M
Shares

$119 Million
0.0% of portfolio

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account